Panacea Life Sciences Holdings, Inc.

PLSH

US69810P1093

Pharmaceuticals

Delayed OTC Markets Other stock markets 10:55:26 2024-04-23 am EDT			5-day change	1st Jan Change
0.1384 ^USD	-19.32%		-21.85%	-7.73%

Apr. 01	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Exactus, Inc. Announces Unaudited Condensed Consolidated Revenue Results for the Three Months Ended June 30, 2021

September 16, 2021 at 04:50 pm EDT

Exactus, Inc. announced unaudited condensed consolidated revenue results for the three months ended June 30, 2021. For the year, the company reported approximately $5.1 million in revenues for the three months ended June 30, 2021.

Latest news about Panacea Life Sciences Holdings, Inc.

Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 01	CI
Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Panacea Life Sciences Holdings, Inc. completed the acquisition of N7 Enterprises, Inc.	23-10-04	CI
Panacea Life Sciences Holdings, Inc. entered into an Asset Purchase Agreement to acquire PÜR LIFE Medical, Inc.	23-10-01	CI
Panacea Life Sciences Holdings, Inc. completed the acquisition of Nitro Kava & Kratom from Gary Wilder, Lizard Juice, LLC, N7 Enterprises, Inc. and New Age Distribution Corp. for $7.8 million.	23-09-29	CI
Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-15	CI
Panacea Life Sciences Holdings, Inc. entered into a non-binding LOI to acquire Sierra Sages Herbs, LLC and Halucenex Life Sciences Inc. for $20 million.	23-08-01	CI
Panacea Life Sciences Holdings, Inc. agreed to acquire Nitro Kava & Kratom.	23-07-09	CI
Panacea Life Sciences Holdings, Inc. entered into agreements acquire 8 Retail Locations in the Tampa, Florida.	23-07-09	CI
Panacea Life Sciences Holdings, Inc. Distribution Division Signs Exclusive Distribution Agreement with QR Joy to Distribute U.S. Top Fume Disposable Vape Devices in the U.K	23-06-15	CI
Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30	CI
Panacea Life Sciences Holdings, Inc. Auditor Raises 'Going Concern' Doubt	23-03-29	CI
Panacea Life Sciences Holdings, Inc. entered into a letter of intent to acquire N7 Enterprises, Inc. for $2.7 million.	23-01-22	CI
Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Panacea Awarded Eight Nutraceutical Purchase Orders as It Expands Its U.S. Based Softgel Manufacturing Services into the Growing Health, Plant-Based Market	22-08-17	CI
Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15	CI
Panacea Life Sciences Holdings, Inc. Announces Resignation of Janice Nerger to Its Board of Directors	22-07-22	CI
Panacea Life Sciences Announces Launch of CBDA Oil Drops as Potential Complementary Treatment for Long COVID	22-07-14	CI
Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-13	CI
Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-31	CI
Panacea Life Sciences Holdings, Inc. Auditor Raises 'Going Concern' Doubt	22-03-30	CI
Panacea Life Sciences Holdings, Inc. Auditor Raises 'Going Concern' Doubt	21-12-16	CI
Panacea Life Sciences Holdings, Inc. announced that it expects to receive $1.1 million in funding from Lincoln Park Capital, LLC	21-11-17	CI
Exactus, Inc. Appoints Janice Nerger as Director	21-10-21	CI

Chart Panacea Life Sciences Holdings, Inc.

Duration

Period

Chart Panacea Life Sciences Holdings, Inc.

More charts

Company Profile

Panacea Life Sciences Holdings, Inc. is a holding company organized as a plant-based natural health ingredient and product company. It specializes in the development, manufacturing, research, and distribution of products with natural health and wellness market segment for both humans and animals. The Companyâs subsidiary, Panacea Life Sciences, Inc. (PLS) is engaged in the production, distribution, research, and manufacturing of nutraceuticals, cannabinoids, mushrooms, kratom, and other natural, plant-based ingredients and products. The Company also offers natural remedies within its branded product lines for every aspect of life, including PANA Health, PANA Beauty, PANA Sport, PANA Pet, PANA Pure, and PANA Life. It also operates 51,000 square foot current good manufacturing practice (cGMP) facility located in Golden, Colorado. The Company, through Panacea Life Sciences Holdings, Inc., manages six retail locations and a distribution center situated in the Tampa, Florida area.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
PANACEA LIFE SCIENCES HOLDINGS, INC.	-7.73%	2.44M
NOVO NORDISK A/S	+24.17%	562B
JOHNSON & JOHNSON	-6.27%	358B
MERCK & CO., INC.	+19.20%	322B
ABBVIE INC.	+7.62%	297B
ASTRAZENECA PLC	+13.45%	219B
NOVARTIS AG	+6.04%	199B
ROCHE HOLDING AG	-10.51%	196B
PFIZER, INC.	-11.79%	149B
AMGEN INC.	-6.35%	146B